Shopping Cart
- Remove All
- Your shopping cart is currently empty
Rosiglitazone hydrochloride (BRL-49653 HCl) is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $33 | In Stock | |
50 mg | $45 | In Stock | |
100 mg | $62 | In Stock | |
200 mg | $88 | In Stock | |
500 mg | $143 | In Stock | |
1 mL x 10 mM (in DMSO) | $39 | In Stock |
Description | Rosiglitazone hydrochloride (BRL-49653 HCl) is a blood glucose-lowering drugs, stimulating insulin secretion by binding to the PPAR receptors in fat cells. |
Targets&IC50 | PPARγ2:100 nM (EC50), PPARγ1:30 nM (EC50) |
In vitro | Bafetinib blocks WT Bcr-Abl autophosphorylation and its downstream kinase activity with IC50 of 11 nM and 22 nM in K562 and 293T cells, respectively. Bafetinib suppresses the growth of the Bcr-Abl-positive cell lines including K562, KU812, and BaF3/wt cells potently without effects on the proliferation of the Bcr-Abl-negative U937 cell line. Moreover, Bafetinib exhibits a dose-dependent antiproliferative effect against Bcr-Abl point mutant cell lines, such as BaF3/E255K cells. [1] In Bcr-Abl+ leukemia cell lines, Bafetinib induces both caspase-mediated and caspase-independent cell death by blocking the phosphorylation of Bcr-Abl. [2] |
Alias | Rosiglitazone HCl, BRL-49653 HCl |
Molecular Weight | 393.89 |
Formula | C18H19N3O3S·HCl |
Cas No. | 302543-62-0 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | Ethanol: 73 mg/mL (185.3 mM) DMSO: 73 mg/mL (185.3 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.